{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:30:28Z","timestamp":1786728628163,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE:<\/jats:title>\n                    <jats:p>The purpose of this study was to determine the role of transcutaneous retrobulbar amphotericin B (TRAMB) injection in COVID-19-related rhino-orbital-cerebral mucormycosis (ROCM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>This prospective interventional case series included 7 eyes of 7 patients diagnosed with COVID-19 ROCM presenting from May to September 2021 at a tertiary care center in North India. Active or recovered cases of COVID-19 with clinical features suggestive of ROCM and early orbital involvement were included. Following functional endoscopic sinus surgery, patients were given TRAMB 3.5 mg\/ml in single ocular quadrant depending upon the muscle involved on contrast-enhanced magnetic resonance imaging (MRI). Patients were followed up for a period of 12 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      All patients were diabetic and COVID-19 reverse transcription\u2013polymerase chain reaction positive. The mean age of patients was 48.4 years \u00b1 11 years, out of which 5 patients were male and 2 were female. The left eye was involved in 57.14% of cases whereas 42.85% of cases had right eye involvement. Presenting complaints were drooping of the upper lid (57.14%;\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 4), proptosis (28.57%;\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 2), facial pain and swelling (85.71%;\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 6), and nasal block (57.14%;\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 4). Stagewise distribution was 3a in four patients (57.14%), 3b in two patients (28.57%), and 4a in one patient. TRAMB injections (median \u2013 3) were given, and improvement was seen in all patients in terms of ocular movements, ptosis, proptosis, and muscle enhancement on MRI scan. Three patients had an increase in intraocular pressure and inflammation which settled within a week with favorable anatomical and functional outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Transcutaneous retrobulbar amphotericin B should be considered an adjunctive treatment modality for ROCM patients with limited orbital disease to preserve ocular function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ojo.ojo_19_23","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T01:02:20Z","timestamp":1719450140000},"page":"198-204","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["To determine the role of transcutaneous retrobulbar amphotericin B in COVID-19-related rhino-orbital-cerebral mucormycosis"],"prefix":"10.4103","volume":"17","author":[{"given":"Rajwinder","family":"Kaur","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Adesh Institute of Medical Sciences and Research, Bathinda, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akriti","family":"Sehgal","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Adesh Institute of Medical Sciences and Research, Bathinda, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Adesh Institute of Medical Sciences and Research, Bathinda, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Budhiraja","sequence":"additional","affiliation":[{"name":"Department of ENT, Adesh Institute of Medical Sciences and Research, Bathinda, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Adesh Institute of Medical Sciences and Research, Bathinda, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupriya","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Adesh Institute of Medical Sciences and Research, Bathinda, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"key":"R1-20260507","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis: Pathophysiology, presentation, and management","volume":"18","author":"Spellberg","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"R2-20260507","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12890-021-01504-8","article-title":"Isolated pulmonary mucormycosis in an immunocompetent patient: A case report and systematic review of the literature","volume":"21","author":"He","year":"2021","journal-title":"BMC Pulm Med"},{"key":"R3-20260507","doi-asserted-by":"crossref","first-page":"e2020233","DOI":"10.4322\/acr.2020.233","article-title":"Isolated cerebral mucormycosis masquerading as a tumor in an immunocompetent patient","volume":"11","author":"Chandra","year":"2021","journal-title":"Autops Case Rep"},{"issue":"Suppl 1","key":"R4-20260507","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R5-20260507","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/jof4020046","article-title":"Mucormycosis: Battle with the deadly enemy over a five-year period in India","volume":"4","author":"Chander","year":"2018","journal-title":"J Fungi (Basel)"},{"key":"R6-20260507","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11046-021-00528-2","article-title":"Coronavirus disease (COVID-19) associated mucormycosis (CAM): Case report and systematic review of literature","volume":"186","author":"Garg","year":"2021","journal-title":"Mycopathologia"},{"key":"R7-20260507","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: A review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"R8-20260507","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1093\/cid\/cir868","article-title":"Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis)","volume":"54","author":"Walsh","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R9-20260507","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India \u2013 Collaborative OPAI-IJO study on Mucormycosis in COVID-19 (COSMIC), report 1","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R10-20260507","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4103\/ijo.IJO_1165_21","article-title":"Code mucor: Guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19","volume":"69","author":"Honavar","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"59","key":"R11-20260507","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/tjosr.tjosr_83_21","article-title":"Transcutaneous retrobulbar amphotericin B and exenteration in rhino-orbital cerebral mucor mycosis: Do we know it all yet?","volume":"1","author":"Naik","year":"2021","journal-title":"TNOA J Ophthalmic Sci Res"},{"key":"R12-20260507","first-page":"e27817","article-title":"Outcomes of Transcutaneous retrobulbar amphotericin B in rhino-orbital-cerebral mucormycosis among patients recovering from COVID-19: A preliminary experience","volume":"14","author":"Sinha","year":"2022","journal-title":"Cureus"},{"key":"R13-20260507","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clinimag.2021.10.014","article-title":"COVID-19 associated rhino-orbito-cerebral mucormycosis: Imaging spectrum and clinico-radiological correlation- a single centre experience","volume":"82","author":"Patel","year":"2022","journal-title":"Clin Imaging"},{"key":"R14-20260507","doi-asserted-by":"crossref","first-page":"100771","DOI":"10.1016\/j.ajoc.2020.100771","article-title":"Rhino-orbital-cerebral mucormycosis (ROCM) and associated cerebritis treated with adjuvant retrobulbar amphotericin B","volume":"19","author":"Safi","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"key":"R15-20260507","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ajo.2021.05.025","article-title":"Outcomes of a modified treatment ladder algorithm using retrobulbar amphotericin b for invasive fungal rhino-orbital sinusitis","volume":"237","author":"Ashraf","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"R16-20260507","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/IOP.0000000000000806","article-title":"Retrobulbar injection of amphotericin B for orbital mucormycosis","volume":"33","author":"Hirabayashi","year":"2017","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R17-20260507","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clinimag.2021.10.014","article-title":"COVID-19 associated rhino-orbito-cerebral mucormycosis: Imaging spectrum and clinico-radiological correlation- a single centre experience","volume":"82","author":"Patel","year":"2022","journal-title":"Clin Imaging"}],"container-title":["Oman Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ojo.ojo_19_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:29:33Z","timestamp":1786724973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ojo.ojo_19_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ojo.ojo_19_23","relation":{},"ISSN":["0974-620X","0974-7842"],"issn-type":[{"value":"0974-620X","type":"print"},{"value":"0974-7842","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"2023-01-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}